PMID: 9438978Jan 24, 1998Paper

Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma

Bioscience, Biotechnology, and Biochemistry
K NakagawaT Miyazawa

Abstract

Tea catechins, (-)-epigallocatechin-3-gallate (EGCg) and (-)-epigallocatechin (EGC), have been reported to suppress oxidation of plasma low density lipoprotein (LDL) in vitro. If dietary catechins can be efficiently incorporated into human blood plasma, anti-atherosclerotic effects in preventing oxidative modification of LDL would be expected. In this study, a newly developed chemiluminescence detection-high pressure liquid chromatography (CL-HPLC) method for measuring plasma catechins was used and the incorporation of EGCg and EGC into human plasma was investigated. Healthy subjects orally ingested 3, 5, or 7 capsules of green tea extract (corresponding to 225, 375, and 525 mg EGCg and 7.5, 12.5, and 17.5 mg EGC, respectively). The plasma EGCg and EGC concentrations before the administration were all below the detection limit (< 2 pmol/ml), but 90 min after, significantly and dose-dependently increased to 657, 4300, and 4410 pmol EGCg/ml, and 35, 144, and 255 pmol EGC/ml, in the subjects who received 3, 5, and 7 capsules, respectively. Both EGCg and EGC levels detected in plasma corresponded to 0.2-2.0% of the ingested amount. Catechin intake had no effect on the basal level of endogenous antioxidants (alpha-tocopherol, beta-c...Continue Reading

Citations

Jun 23, 2000·Annals of the New York Academy of Sciences·S V Jovanovic, M G Simic
Nov 15, 2002·International Journal of Cancer. Journal International Du Cancer·Simon E TobiTrevor J McMillan
Jan 24, 2003·Annual Review of Pharmacology and Toxicology·Michael S Denison, Scott R Nagy
Oct 8, 2003·BioFactors·Hironori TsuchiyaHiroshi Takeuchi
Jan 11, 2005·The American Journal of Clinical Nutrition·Tomonori NagaoIchiro Tokimitsu
Nov 17, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Snezana MirkovFederico Innocenti
Oct 28, 2008·Expert Opinion on Drug Metabolism & Toxicology·Hitoshi AshidaItsuko Fukuda
Feb 16, 2010·Nutrition and Cancer·Q Ping Dou
Apr 14, 2012·Journal of Atherosclerosis and Thrombosis·Woo-Jeong OkHwa-Jin Park
Mar 1, 2007·Expert Opinion on Drug Discovery·Suresh Kumar GuptaShyam Sunder Agrawal
Feb 22, 2018·PloS One·Catharina SchollJulia Carolin Stingl
Jun 20, 2019·Drug Development and Industrial Pharmacy·Nithya Ramesh, Abul Kalam Azad Mandal
Sep 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yoshitake BabaTakanobu Takihara
Aug 25, 2001·The British Journal of Nutrition·H CrewsG Williamson
Jul 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jaya Bharathi Vaidyanathan, Thomas Walle
Jul 8, 1999·The Journal of Nutrition·K SugiyamaS Saeki
Aug 15, 2003·International Journal of Cancer. Journal International Du Cancer·Koen BrusselmansJohannes V Swinnen
Aug 17, 2006·Nutritional Neuroscience·Andrea ZiniAlan Crozier
Nov 16, 2005·Medicine and Science in Sports and Exercise·Akira ShimotoyodomeIchiro Tokimitsu
Sep 1, 2005·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Raymond CooperDorothy M Morré
Apr 7, 2006·The Journal of Pharmacy and Pharmacology·Shereen Ayoub, Matthias F Melzig
Feb 10, 2009·European Journal of Clinical Pharmacology·Gabriela MazzantiSabina Mastrangelo
Jul 7, 2011·Expert Opinion on Drug Discovery·Thomas J Smith
Mar 25, 2015·BioMed Research International·Laura MarínFelipe Lombó
Jun 9, 2016·Nutrition Journal·Neha Atulkumar SinghZaved Ahmed Khan
May 24, 2016·Nutrients·Andreia GranjaSalette Reis
Aug 15, 2018·BioMed Research International·Wanda C Reygaert
Mar 19, 2020·Nutrients·Priyanga SelvakumarAshakumary Lakshmikuttyamma

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.